| 0 |
INTRAVASCULAR GAS |
1 |
0.1000 |
| 1 |
DEVICE TEMPERATURE ISSUE |
1 |
0.0133 |
| 2 |
VASCULAR ACCESS SITE EXTRAVASATION |
1 |
0.0115 |
| 3 |
PRODUCT BARCODE ISSUE |
4 |
0.0104 |
| 4 |
CONGENITAL NEUROLOGICAL DISORDER |
1 |
0.0085 |
| 5 |
WRONG DRUG |
1 |
0.0026 |
| 6 |
FEEDING INTOLERANCE |
1 |
0.0022 |
| 7 |
CRANIOSYNOSTOSIS |
1 |
0.0012 |
| 8 |
PRODUCT SELECTION ERROR |
1 |
0.0009 |
| 9 |
NEPHROCALCINOSIS |
1 |
0.0008 |
| 10 |
OTITIS EXTERNA |
1 |
0.0008 |
| 11 |
RETINAL DEGENERATION |
1 |
0.0008 |
| 12 |
GAZE PALSY |
1 |
0.0006 |
| 13 |
HYPOPROTEINAEMIA |
1 |
0.0005 |
| 14 |
PRODUCT PACKAGING CONFUSION |
1 |
0.0004 |
| 15 |
TALIPES |
1 |
0.0003 |
| 16 |
ELECTROENCEPHALOGRAM ABNORMAL |
1 |
0.0003 |
| 17 |
NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL |
1 |
0.0003 |
| 18 |
PRODUCT LABEL ISSUE |
2 |
0.0003 |
| 19 |
BLOOD PHOSPHORUS DECREASED |
1 |
0.0003 |
| 20 |
CEREBRAL ATROPHY |
1 |
0.0003 |
| 21 |
ESCHERICHIA URINARY TRACT INFECTION |
1 |
0.0002 |
| 22 |
ATELECTASIS |
2 |
0.0002 |
| 23 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 24 |
MALABSORPTION |
1 |
0.0002 |
| 25 |
NORMAL NEWBORN |
1 |
0.0002 |
| 26 |
BLOOD CALCIUM DECREASED |
2 |
0.0002 |
| 27 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 28 |
COVID-19 PNEUMONIA |
2 |
0.0002 |
| 29 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 30 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 31 |
UROSEPSIS |
1 |
0.0001 |
| 32 |
THROMBOTIC MICROANGIOPATHY |
1 |
0.0001 |
| 33 |
HYPOTHERMIA |
1 |
0.0001 |
| 34 |
DRUG LEVEL DECREASED |
1 |
0.0001 |
| 35 |
TACHYPNOEA |
1 |
0.0001 |
| 36 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 37 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
2 |
0.0001 |
| 38 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 39 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 40 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 41 |
PALLOR |
1 |
0.0000 |
| 42 |
FEELING COLD |
1 |
0.0000 |
| 43 |
CATARACT |
2 |
0.0000 |
| 44 |
EPILEPSY |
1 |
0.0000 |
| 45 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 46 |
EYE DISORDER |
1 |
0.0000 |
| 47 |
DEVICE USE ERROR |
1 |
0.0000 |
| 48 |
HYPOXIA |
1 |
0.0000 |
| 49 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 50 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 51 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 52 |
GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0000 |
| 53 |
TACHYCARDIA |
2 |
0.0000 |
| 54 |
BRADYCARDIA |
1 |
0.0000 |
| 55 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 56 |
CHILLS |
2 |
0.0000 |
| 57 |
DISCOMFORT |
1 |
0.0000 |
| 58 |
PRODUCT USE IN UNAPPROVED INDICATION |
4 |
0.0000 |
| 59 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 60 |
HYPOTENSION |
3 |
0.0000 |
| 61 |
BRONCHITIS |
1 |
0.0000 |
| 62 |
THROMBOSIS |
1 |
0.0000 |
| 63 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 64 |
URTICARIA |
2 |
0.0000 |
| 65 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 66 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 67 |
SWELLING |
1 |
0.0000 |
| 68 |
DYSPHAGIA |
1 |
0.0000 |
| 69 |
SYNCOPE |
1 |
0.0000 |
| 70 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 71 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 72 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 73 |
PYREXIA |
2 |
0.0000 |
| 74 |
MUSCLE SPASMS |
1 |
0.0000 |
| 75 |
HYPERTENSION |
1 |
0.0000 |
| 76 |
COUGH |
1 |
0.0000 |
| 77 |
DEATH |
3 |
0.0000 |
| 78 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 79 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 80 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 81 |
PAIN |
2 |
0.0000 |
| 82 |
FALL |
1 |
0.0000 |
| 83 |
PRURITUS |
1 |
0.0000 |
| 84 |
RASH |
1 |
0.0000 |
| 85 |
OFF LABEL USE |
2 |
0.0000 |
| 86 |
VOMITING |
1 |
0.0000 |
| 87 |
HEADACHE |
1 |
0.0000 |
| 88 |
NAUSEA |
1 |
0.0000 |